Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Liberum Biotech logo — The Protein Discovery Company

Liberum Biotech

The Protein Discovery Company

Founded 2019 6 employees Seed Total: $1.80M Biotechnology, Manufacturing

General Information

Company Name Liberum Biotech
Founded Year 2019
Employees 6
Industries Biotechnology, Manufacturing
Funding Stage Seed
Social

Get notified when Liberum Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Liberum Biotech

Liberum Biotech is a seed-stage venture that focuses on accelerating enzyme and antibody discovery through its cutting-edge proprietary cell-free protein synthesis platform. Founded in 2019, it operates within the biotechnology and manufacturing industries. The company recently secured a significant $1.80M Seed Round investment on 24 July 2023 from prominent investors such as SOSV, TechU Ventures, and Savantus Ventures. With its forward-looking approach and innovative technology, Liberum Biotech, also known as "The Protein Discovery Company," is poised to make a profound impact in the biotech industry landscape.

Taxonomy: protein discovery, enzyme discovery, antibody discovery, cell-free protein synthesis, startup, seed-stage venture, innovation, biomedical research, biotech platform

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.80M 3
SOSV TechU Ventures Savantus Ventures
24 Jul 2023
Non Equity Assistance Unknown 1
Creative Destruction Lab
01 Jan 2021
Pre Seed Round Unknown 1
indiebio
12 Aug 2020
Pre Seed Round Unknown 1
UTEST
01 Jan 2019

Liberum Biotech Alternatives & Competitors

Liberum Biotech vs
Evozyne
Evozyne United States

Generative AI-powered drug discovery platform and product development

Series B
54 employees
Biotechnology, Pharmaceutical
Liberum Biotech vs
A-Alpha Bio
A-Alpha Bio United States

The protein-protein interaction company

Grant
50 employees
Biotechnology, Health Care
Compare Liberum Biotech vs A-Alpha Bio
Liberum Biotech vs
AI Proteins
AI Proteins United States

The perfect medicine is not found

Series A
39 employees
AI, Biotechnology

FAQ About Liberum Biotech

The Protein Discovery Company
Liberum Biotech was founded in 2019.
Liberum Biotech operates in the following industries: Biotechnology, Manufacturing.
Liberum Biotech has approximately 6 employees.
Liberum Biotech has completed 4 funding rounds, raising a total of $1.80M. The latest funding stage is Seed.
Top alternatives and competitors to Liberum Biotech include Evozyne, A-Alpha Bio, AI Proteins, TRIANA Biomedicines, SilicoGenesis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Liberum Biotech and Evozyne are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Liberum Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy